Licoflavone multi-element supramolecular inclusion compound and preparation method and application of gastric retention sustained release preparation of licoflavone multi-element supramolecular inclusion compound
By preparing glycyrrhizin flavonoid multi-component supramolecular inclusion complexes, the problem of low solubility of glycyrrhizin flavonoids in water and gastric juice was solved, achieving long-term retention and sustained release in the stomach, thus improving bioavailability and efficacy.
Patent Information
- Application Number
- CN202411143149.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-20
- Publication Date
- 2024-11-26
AI Technical Summary
Existing licorice flavonoid preparations have low solubility in water and gastric juice, resulting in incomplete release and affecting efficacy. Furthermore, the release rate is too fast, failing to effectively prolong the residence time in the stomach and the duration of action on target organs.
A multi-component supramolecular inclusion complex was prepared by combining glycyrrhizin with poloxamer, cyclodextrin and hydroxypropyl methylcellulose. The complex was then stabilized by spray drying technology, which improved its water solubility and gastric juice solubility and slowed down the release rate.
It significantly improved the solubility and bioavailability of glycyrrhizin in gastric juice, prolonged its residence time in the stomach, enhanced the drug's effect in the gastrointestinal tract, reduced the frequency of administration, and improved clinical efficacy.
Smart Images

Figure CN119015440A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of biomedicine, and specifically relates to a preparation method and application of a glycyrrhiza flavonoids multi-component supramolecular inclusion compound and a gastric retention sustained-release preparation thereof. Background Art
[0002] Licorice flavonoids are an important class of active ingredients in licorice. The main chemical components are licorice, isoliquiritigenin, licorice chalcone A, isoliquiritigenin, etc. It has significant pharmacological effects such as antibacterial, liver protection, antioxidant, antiviral, anti-ulcer, anti-tumor, anti-pigmentation, and anti-arrhythmia. It can treat and repair gastric ulcers and duodenal ulcers, improve symptoms such as epigastric pain, poor appetite, and abdominal distension, improve blood supply to gastric mucosal tissue, protect and repair gastric mucosa, scavenge free radicals, inhibit the release of inflammatory factors, and reduce the occurrence of mucosal inflammation. Licorice flavonoids also have an inhibitory effect on the growth of various cancer cells, and can inhibit the proliferation of tumor cells by blocking the cell cycle, affecting the regulation of tumor cell apoptosis genes, and inhibiting tumor cell angiogenesis.
[0003] A search of existing patents and literatures shows that the following are relevant to the present invention: ① CN201110002457.2 discloses a method for preparing water-soluble glycyrrhizin by encapsulating glycyrrhizin with β-cyclodextrin; ② Zhu Hongxia et al. developed a glycyrrhizin-HP-β-CD inclusion compound with a solubility of 1.6358 mg / mL (Zhu Hongxia et al., Preparation and solubilization of glycyrrhizin-HP-β-CD inclusion compound [J], Food and Drug, 2014, 16(4):381-383); ③ CN201710076778.4 discloses a glycyrrhizin-HP-β-CD inclusion compound comprising glycyrrhizin, stearyl alcohol and 1,2-dimethoxy- ... ④ Lu Liemei et al., Study on the formulation and process optimization of licorice flavonoids intragastric floating tablets [J], Pharmacy and Clinical Research, 2018, 26(1):22-25, using hydroxypropyl methylcellulose, sodium carboxymethyl cellulose, octadecyl alcohol, polyethylene glycol 6000, lactose and other excipients to prepare licorice flavonoids intragastric floating tablets, but the 1h cumulative release rate is 30-40%, and the release rate is fast. The above literature and patent reports on the public technology, the solubility of licorice flavonoids in water and gastric juice is still low, the concentration of released gastric juice drugs is very low, the drug release is incomplete, the drug release is fast in a short time, and the efficacy is affected.
[0004] Based on this, it is hoped to provide a solution that can increase the solubility of glycyrrhizin, improve the solubility of the drug in gastric juice, prolong the retention time of the drug in the stomach, increase the action time of the drug in the target organs of the gastrointestinal tract and expand absorption, improve the bioavailability of the drug, improve the clinical efficacy, reduce the number of dosing times, and increase patient compliance. Summary of the invention
[0005] The purpose of the present invention is to provide a glycyrrhizin multi-element supramolecular inclusion compound, which can significantly improve the water solubility and gastric juice solubility of glycyrrhizin, increase the retention time of glycyrrhizin in the stomach, and improve the bioavailability of glycyrrhizin.
[0006] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:
[0007] The invention provides a glycyrrhizin multi-element supramolecular inclusion compound, which is prepared from the following raw materials in parts by weight: 10 parts of glycyrrhizin, 10 to 30 parts of poloxamer, 10 to 100 parts of cyclodextrin and 1 to 10 parts of hydroxypropyl methylcellulose.
[0008] The present invention provides a method for preparing the above-mentioned glycyrrhiza flavonoid multi-element supramolecular inclusion compound, comprising the following steps:
[0009] (1) mixing glycyrrhizin and poloxamer with ethanol to obtain a mixed solution 1, then adding water to the mixed solution 1 and continuing to mix, and then adding cyclodextrin and stirring to obtain a mixed solution 2;
[0010] (2) adding water to hydroxypropyl methylcellulose and stirring to obtain a mixed solution 3, mixing the mixed solution 3 with the mixed solution 2 described in step (1), and drying to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0011] Preferably, the licorice flavonoids are licorice flavonoids extracts extracted from the residue after water extraction of licorice, and the content of flavonoids in the licorice flavonoids is ≥ 80.0%;
[0012] Preferably, the poloxamer is poloxamer 188;
[0013] Preferably, the cyclodextrin is β-cyclodextrin or hydroxypropyl-β-cyclodextrin;
[0014] Preferably, the hypromellose is hypromellose K100M.
[0015] Preferably, in step (1), the mass ratio of the glycyrrhizin flavonoids to ethanol is 10:40-120, the volume fraction of the ethanol is 90-95%, and the mixing temperature with the ethanol is 40-60°C.
[0016] Preferably, the mass ratio of the glycyrrhiza flavonoids to water in step (1) is 10:100-400;
[0017] The stirring temperature is 40-60° C. and the stirring time is 0.5-2 h.
[0018] Preferably, the mass ratio of the hypromellose to water in step (2) is 1:40-50;
[0019] The stirring temperature is 30-40° C. and the stirring time is 3-5 hours.
[0020] Preferably, in step (2), the temperature of the mixed solution 3 and the mixed solution 2 when mixed is 30-40°C.
[0021] Preferably, the drying in step (2) is spray drying, with an air inlet temperature of 160-180°C and an air outlet temperature of 70-80°C.
[0022] The present invention also provides a glycyrrhizin multi-component supramolecular inclusion compound gastric retention sustained-release preparation, which is composed of the glycyrrhizin multi-component supramolecular inclusion compound, microcrystalline cellulose and sodium bicarbonate in a mass ratio of 100:5-15:5-10.
[0023] The present invention provides the use of the glycyrrhizin flavonoids multi-component supramolecular inclusion compound or the glycyrrhizin flavonoids multi-component supramolecular inclusion compound gastric retention sustained-release preparation in the preparation of drugs for treating gastric ulcer or anti-tumor.
[0024] The invention prepares a multi-component supramolecular inclusion compound of glycyrrhizin with cyclodextrin, poloxamer and hydroxypropyl methylcellulose, which can significantly improve the water solubility and gastric juice solubility of glycyrrhizin and has high stability; the glycyrrhizin multi-component supramolecular inclusion compound prepared by the invention can effectively delay the dissolution and release speed of glycyrrhizin, and further delay the release speed of glycyrrhizin in gastric juice, and the sustained release effect is significantly better than that of the glycyrrhizin-cyclodextrin-poloxamer ternary inclusion compound.
[0025] The results of thermal analysis (DSC) test show that the glycyrrhizin flavonoids multi-component supramolecular inclusion complex prepared by the present invention forms a new phase; the HPLC liquid phase spectrum proves that the glycyrrhizin flavonoids component is included in the inclusion complex, and the multi-component supramolecular inclusion complex does not change the chemical composition of glycyrrhizin flavonoids.
[0026] The multi-element supramolecular inclusion compound gastric retention sustained-release preparation of glycyrrhizin flavonoids provided by the present invention can significantly prolong the retention time of glycyrrhizin flavonoids in the stomach, float rapidly after administration in gastric juice, with a floating start time of less than 10 seconds and a continuous floating time of more than 12 hours, a release rate of more than 88.7% within 8 hours, up to 98.2%, and a cumulative release rate of more than 95% within 12 hours, thereby improving the gastric retention absorption effect and bioavailability of glycyrrhizin flavonoids. Animal studies have found that the multi-element supramolecular inclusion compound gastric retention sustained-release preparation of glycyrrhizin flavonoids provided by the present invention has a gastric retention time significantly longer than that of a common glycyrrhizin flavonoids preparation, has a significant anti-ulcer effect on a gastric ulcer animal model, has a significant anti-ulcer and repair effect on a gastric ulcer surface, and can significantly improve the bioavailability of glycyrrhizin flavonoids in rabbits.
[0027] In summary, the glycyrrhizin multi-element supramolecular inclusion compound and the gastric retention sustained-release preparation thereof of the present invention can significantly improve the water solubility and solubility of glycyrrhizin in gastric juice, delay the release rate of glycyrrhizin in gastric juice, increase the retention time of glycyrrhizin in the stomach, increase the absorption effect of glycyrrhizin in the stomach or duodenum, improve bioavailability, reduce the dosage and frequency of administration, and have a significant therapeutic effect on gastric ulcers and the like. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 This is the DSC spectrum of the licorice flavonoids raw material in Experimental Example 1.
[0029] Figure 2 This is the DSC spectrum of hydroxypropyl-β-cyclodextrin in Experimental Example 1.
[0030] Figure 3 This is the DSC spectrum of β-cyclodextrin in Experimental Example 1.
[0031] Figure 4 This is the DSC spectrum of poloxamer in Experimental Example 1.
[0032] Figure 5 This is the DSC spectrum of Hydroxypropyl Methylcellulose in Test Example 1.
[0033] Figure 6 This is the DSC spectrum of the physical mixture of glycyrrhizin, hydroxypropyl-β-cyclodextrin, poloxamer and hypromellose in Experimental Example 1.
[0034] Figure 7 This is the DSC spectrum of the physical mixture of glycyrrhizin, β-cyclodextrin, poloxamer and hypromellose in Experimental Example 1.
[0035] Figure 8 This is the DSC spectrum of the glycyrrhiza flavonoids multi-component supramolecular inclusion complex prepared in Example 1 of Experimental Example 1.
[0036] Fig. 9 This is the DSC spectrum of the glycyrrhiza flavonoids multi-component supramolecular inclusion complex prepared in Example 2 of Experimental Example 1.
[0037] Fig.10 This is the liquid chromatogram of the second washing solution of ethyl acetate in Experimental Example 2.
[0038] Fig.11 This is the liquid chromatogram of the glycyrrhizin flavonoids multi-component supramolecular inclusion complex after two ethyl acetate washes in Experimental Example 2.
[0039] Fig.12 This is the liquid chromatogram of the original drug of licorice flavonoids in Experimental Example 2.
[0040] Fig.13 This is the cumulative dissolution curve of glycyrrhiza flavonoids in Experimental Example 6.
[0041] Fig.14 This is the cumulative release curve of glycyrrhiza flavonoids in Test Example 7.
[0042] Fig.15 This is the blood concentration-time curve of Licoricechalcone A in Test Example 10. DETAILED DESCRIPTION
[0043] The technical solutions provided by the present invention are described in detail below in conjunction with the embodiments, but they should not be construed as limiting the protection scope of the present invention.
[0044] Example 1 A multi-component supramolecular inclusion compound of licorice flavonoids, the preparation method is as follows:
[0045] (1) 10 g of licorice flavonoids with a flavonoid content of 80%, 10 g of poloxamer 188 and 40 g of 95% ethanol were stirred and dissolved at 50° C. to obtain a mixed solution 1, 100 g of water was added and stirred evenly, and then 10 g of hydroxypropyl-β-cyclodextrin was added and stirred at 50° C. for 1 h to obtain a mixed solution 2;
[0046] (2) Add 200 g of water to 5 g of hydroxypropyl methylcellulose K100M, stir at 40° C. for 3 h, stir evenly with the mixed solution 2 of step (1) at 40° C., and then spray dry. During spray drying, the inlet air temperature is 170° C. and the outlet air temperature is 70° C., to obtain the glycyrrhiza flavonoid multi-element supramolecular inclusion complex.
[0047] Example 2 A multi-component supramolecular inclusion compound of licorice flavonoids, the preparation method is as follows:
[0048] (1) 10 g of licorice flavonoids with a flavonoid content of 90%, 20 g of poloxamer 188 and 75 g of 95% ethanol were stirred and dissolved at 60° C. to obtain a mixed solution 1, 180 g of water was added and stirred evenly, and then 20 g of β-cyclodextrin was added and stirred at 60° C. for 1.5 h to obtain a mixed solution 2;
[0049] (2) Add 126 g of water to 3 g of hydroxypropyl methylcellulose K100M, stir at 40° C. for 4 h, stir evenly with the mixed solution 2 of step (1) at 40° C., and then spray dry. During spray drying, the inlet air temperature is 180° C. and the outlet air temperature is 75° C., to obtain the glycyrrhiza flavonoid multi-element supramolecular inclusion complex.
[0050] Example 3 A multi-component supramolecular inclusion compound of licorice flavonoids, the preparation method is as follows:
[0051] (1) 10 g of licorice flavonoids with a flavonoid content of 83%, 30 g of poloxamer 188 and 120 g of 95% ethanol were stirred and dissolved at 40° C. to obtain a mixed solution 1, 280 g of water was added and stirred evenly, and then 30 g of hydroxypropyl-β-cyclodextrin was added and stirred at 40° C. for 2 h to obtain a mixed solution 2;
[0052] (2) Add 40 g of water to 1 g of hydroxypropyl methylcellulose K100M, stir at 30° C. for 5 h, stir evenly with the mixed solution 2 of step (1) at 30° C., and then spray dry. During spray drying, the inlet air temperature is 160° C. and the outlet air temperature is 80° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0053] Example 4 A multi-component supramolecular inclusion compound of licorice flavonoids, prepared by the following method:
[0054] (1) 10 g of licorice flavonoids with a flavonoid content of 85%, 10 g of poloxamer 188 and 40 g of 95% ethanol were stirred and dissolved at 55° C. to obtain a mixed solution 1, 160 g of water was added and stirred evenly, and then 40 g of β-cyclodextrin was added and stirred at 55° C. for 0.5 h to obtain a mixed solution 2;
[0055] (2) Add 322 g of water to 7 g of hydroxypropyl methylcellulose K100M, stir at 30° C. for 3 h, stir evenly with the mixed solution 2 of step (1) at 30° C., and then spray dry. During spray drying, the inlet air temperature is 170° C. and the outlet air temperature is 80° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0056] Example 5 A multi-component supramolecular inclusion compound of licorice flavonoids, prepared by the following method:
[0057] (1) 10 g of licorice flavonoids with a flavonoid content of 95%, 20 g of poloxamer 188 and 75 g of 95% ethanol were stirred and dissolved at 45° C. to obtain a mixed solution 1, 270 g of water was added and stirred evenly, and then 50 g of hydroxypropyl-β-cyclodextrin was added and stirred at 45° C. for 1.5 h to obtain a mixed solution 2;
[0058] (2) Add 432 g of water to 9 g of hydroxypropyl methylcellulose K100M, stir at 35° C. for 4 h, stir evenly with the solution of step (1) at 35° C., and then spray dry. During spray drying, the inlet air temperature is 180° C. and the outlet air temperature is 70° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0059] Example 6 A multi-component supramolecular inclusion compound of licorice flavonoids, prepared by the following method:
[0060] (1) 10 g of licorice flavonoids with a flavonoid content of 85%, 30 g of poloxamer 188 and 120 g of 95% ethanol were stirred and dissolved at 50° C. to obtain a mixed solution 1, 320 g of water was added and stirred evenly, and then 60 g of β-cyclodextrin was added and stirred at 50° C. for 2 h to obtain a mixed solution 2;
[0061] (2) Add 500 g of water to 10 g of hydroxypropyl methylcellulose K100M, stir at 35° C. for 5 h, stir evenly with the mixed solution 2 of step (1) at 35° C., and then spray dry. During spray drying, the inlet air temperature is 160° C. and the outlet air temperature is 75° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0062] Example 7 A multi-component supramolecular inclusion compound of licorice flavonoids, prepared by the following method:
[0063] (1) 10 g of licorice flavonoids with a flavonoid content of 99%, 20 g of poloxamer 188 and 60 g of 95% ethanol were stirred and dissolved at 60° C. to obtain a mixed solution 1, 300 g of water was added and stirred evenly, and 70 g of hydroxypropyl-β-cyclodextrin was added and stirred at 60° C. for 0.5 h to obtain a mixed solution 2;
[0064] (2) Add 392 g of water to 8 g of hydroxypropyl methylcellulose K100M, stir at 40° C. for 3 h, stir evenly with the mixed solution 2 of step (1) at 40° C., and then spray dry. During spray drying, the inlet air temperature is 170° C. and the outlet air temperature is 75° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0065] Example 8 A multi-component supramolecular inclusion compound of glycyrrhiza flavonoids, prepared by the following method:
[0066] (1) 10 g of licorice flavonoids with a flavonoid content of 82%, 20 g of poloxamer 188 and 75 g of 95% ethanol were stirred and dissolved at 40° C. to obtain a mixed solution 1, 270 g of water was added and stirred evenly, and then 80 g of β-cyclodextrin was added and stirred at 40° C. for 1 hour to obtain a mixed solution 2;
[0067] (2) Add 282 g of water to 6 g of hydroxypropyl methylcellulose K100M, stir at 40° C. for 4 h, stir evenly with the mixed solution 2 of step (1) at 40° C., and then spray dry. During spray drying, the inlet air temperature is 180° C. and the outlet air temperature is 80° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0068] Example 9 A multi-component supramolecular inclusion compound of licorice flavonoids, prepared by the following method:
[0069] (1) 10 g of licorice flavonoids with a flavonoid content of 88%, 30 g of poloxamer 188 and 120 g of 95% ethanol were stirred and dissolved at 55° C. to obtain a mixed solution 1, 320 g of water was added and stirred evenly, and then 90 g of hydroxypropyl-β-cyclodextrin was added and stirred at 55° C. for 2 h to obtain a mixed solution 2;
[0070] (2) Add 180 g of water to 4 g of hydroxypropyl methylcellulose K100M, stir at 30° C. for 5 h, stir evenly with the mixed solution 2 of step (1) at 30° C., and then spray dry. During spray drying, the inlet air temperature is 160° C. and the outlet air temperature is 70° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0071] Example 10 A multi-component supramolecular inclusion compound of glycyrrhiza flavonoids, prepared by the following method:
[0072] (1) 10 g of licorice flavonoids with a flavonoid content of 87%, 30 g of poloxamer 188 and 80 g of 95% ethanol were stirred and dissolved at 45° C. to obtain a mixed solution 1, 400 g of water was added and stirred evenly, and then 100 g of β-cyclodextrin was added and stirred at 45° C. for 1.5 h to obtain a mixed solution 2;
[0073] (2) Add 96 g of water to 2 g of hydroxypropyl methylcellulose K100M, stir at 30° C. for 3 h, stir evenly with the mixed solution 2 of step (1) at 30° C., and then spray dry. During spray drying, the inlet air temperature is 170° C. and the outlet air temperature is 70° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0074] Example 11 A multi-component supramolecular inclusion compound of glycyrrhiza flavonoids, prepared by the following method:
[0075] (1) 10 g of licorice flavonoids with a flavonoid content of 80%, 20 g of poloxamer 188 and 75 g of 95% ethanol were stirred and dissolved at 50° C. to obtain a mixed solution 1, 210 g of water was added and stirred evenly, and then 30 g of hydroxypropyl-β-cyclodextrin was added and stirred at 50° C. for 1 h to obtain a mixed solution 2;
[0076] (2) Add 123 g of water to 3 g of hydroxypropyl methylcellulose K100M, stir at 35° C. for 4 h, stir evenly with the mixed solution 2 of step (1) at 35° C., and then spray dry. During spray drying, the inlet air temperature is 180° C. and the outlet air temperature is 75° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0077] Example 12 A multi-component supramolecular inclusion compound of glycyrrhiza flavonoids, prepared by the following method:
[0078] (1) 10 g of licorice flavonoids with a flavonoid content of 96%, 10 g of poloxamer 188 and 60 g of 95% ethanol were stirred and dissolved at 60° C. to obtain a mixed solution 1, 180 g of water was added and stirred evenly, and then 50 g of β-cyclodextrin was added and stirred at 60° C. for 0.5 h to obtain a mixed solution 2;
[0079] (2) Add 200 g of water to 4 g of hydroxypropyl methylcellulose K100M, stir at 35° C. for 5 h, stir evenly with the mixed solution 2 of step (1) at 35° C., and then spray dry. During spray drying, the inlet air temperature is 160° C. and the outlet air temperature is 80° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0080] Example 13 A multi-component supramolecular inclusion compound of glycyrrhiza flavonoids, prepared by the following method:
[0081] (1) 10 g of licorice flavonoids with a flavonoid content of 92%, 10 g of poloxamer 188 and 40 g of 95% ethanol were stirred and dissolved at 40° C. to obtain a mixed solution 1, 100 g of water was added and stirred evenly, and then 20 g of hydroxypropyl-β-cyclodextrin was added and stirred at 40° C. for 1 hour to obtain a mixed solution 2;
[0082] (2) Add 240 g of water to 6 g of hydroxypropyl methylcellulose K100M, stir at 40° C. for 3 h, stir evenly with the mixed solution 2 of step (1) at 40° C., and then spray dry. During spray drying, the inlet air temperature is 170° C. and the outlet air temperature is 80° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0083] Example 14 A multi-component supramolecular inclusion compound of glycyrrhiza flavonoids, prepared by the following method:
[0084] (1) 10 g of licorice flavonoids with a flavonoid content of 81%, 20 g of poloxamer 188 and 75 g of 95% ethanol were stirred and dissolved at 55° C. to obtain a mixed solution 1, 180 g of water was added and stirred evenly, and then 10 g of β-cyclodextrin was added and stirred at 55° C. for 1.5 h to obtain a mixed solution 2;
[0085] (2) Add 215 g of water to 5 g of hydroxypropyl methylcellulose K100M, stir at 40° C. for 4 h, stir evenly with the mixed solution 2 of step (1) at 40° C., and then spray dry. During spray drying, the inlet air temperature is 180° C. and the outlet air temperature is 70° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0086] Example 15 A multi-component supramolecular inclusion compound of glycyrrhiza flavonoids, prepared by the following method:
[0087] (1) 10 g of licorice flavonoids with a flavonoid content of 86%, 30 g of poloxamer 188 and 120 g of 95% ethanol were stirred and dissolved at 45° C. to obtain a mixed solution 1, 280 g of water was added and stirred evenly, and then 40 g of hydroxypropyl-β-cyclodextrin was added and stirred at 45° C. for 0.5 h to obtain a mixed solution 2;
[0088] (2) Add 90 g of water to 2 g of hydroxypropyl methylcellulose K100M, stir at 40° C. for 5 h, stir evenly with the mixed solution 2 of step (1) at 40° C., and then spray dry. During spray drying, the inlet air temperature is 160° C. and the outlet air temperature is 75° C., to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
[0089] Example 16 to Example 30
[0090] After the raw materials are mixed evenly according to the formula, dry granulation is performed and tableting is performed to obtain a glycyrrhizin flavonoid multi-element supramolecular inclusion compound gastric retention sustained-release preparation. The formulas of Examples 16 to 30 are shown in Table 1:
[0091] Table 1 Formulations of Examples 16 to 30
[0092]
[0093]
[0094] Comparative Example 1 A glycyrrhizin-hydroxypropyl-β-cyclodextrin binary inclusion complex, prepared by grinding 10 g of glycyrrhizin with a flavonoid content of 80%, 10 g of hydroxypropyl-β-cyclodextrin, and 10 g of water for 1 hour, drying and grinding at 70°C to obtain a glycyrrhizin-hydroxypropyl-β-cyclodextrin binary inclusion complex.
[0095] Comparative Example 2 A glycyrrhizin-β-cyclodextrin binary inclusion complex is prepared by grinding 10 g of glycyrrhizin with a flavonoid content of 90%, 20 g of β-cyclodextrin, and 30 g of water for 1 hour, drying and grinding at 70°C to obtain a glycyrrhizin-β-cyclodextrin binary inclusion complex.
[0096] Comparative Example 3 A glycyrrhizin-hydroxypropyl-β-cyclodextrin-poloxamer ternary inclusion complex, prepared by the following method: 10 g of glycyrrhizin with a flavonoid content of 80%, 10 g of poloxamer 188 and 40 g of 95% ethanol were stirred and dissolved at 50°C, 100 g of water was added and stirred evenly, and then 10 g of hydroxypropyl-β-cyclodextrin was added and stirred at 50°C for 1 hour, followed by spray drying. During spray drying, the inlet air temperature was 170°C and the outlet air temperature was 70°C to obtain a glycyrrhizin-hydroxypropyl-β-cyclodextrin-poloxamer ternary inclusion complex.
[0097] Comparative Example 4 A glycyrrhizin-β-cyclodextrin-poloxamer ternary inclusion complex, prepared by the following method: 10 g of glycyrrhizin with a flavonoid content of 90%, 20 g of poloxamer 188 and 75 g of 95% ethanol were stirred and dissolved at 60°C, 180 g of water was added and stirred evenly, and 20 g of β-cyclodextrin was added and stirred at 60°C for 1.5 h, followed by spray drying. During spray drying, the inlet air temperature was 180°C and the outlet air temperature was 75°C to obtain a glycyrrhizin-β-cyclodextrin-poloxamer ternary inclusion complex.
[0098] Comparative Example 5 A glycyrrhizin-poloxamer suspension is prepared by stirring and dissolving 10 g of glycyrrhizin with a flavonoid content of 80%, 10 g of poloxamer 188 and 40 g of 95% ethanol at 50° C., and then drying under reduced pressure to obtain a glycyrrhizin-poloxamer suspension.
[0099] Comparative Examples 6 to 9
[0100] After uniformly mixing the raw materials according to the following formula, dry granulation is performed and tableting is performed to obtain the corresponding inclusion compound tablets.
[0101] Table 2 Formulas of Comparative Examples 6 to 9
[0102]
[0103]
[0104] Comparative Example 10 A glycyrrhizin-poloxamer suspension tablet, prepared by the following method: 60 g of glycyrrhizin-poloxamer suspension was obtained according to the preparation method of Comparative Example 5, 30 g of hydroxypropyl-β-cyclodextrin, 15 g of hydroxypropyl methylcellulose K100M, 5.25 g of microcrystalline cellulose, and 5.25 g of sodium bicarbonate were added and mixed evenly, and dry granulated and tableted to obtain glycyrrhizin-poloxamer suspension tablets.
[0105] Comparative Example 11 A glycyrrhiza flavonoid physical mixture tablet, the preparation method is as follows: 30g of glycyrrhiza flavonoids with a flavonoid content of 80%, 30g of poloxamer 188, 30g of hydroxypropyl-β-cyclodextrin, 15g of hydroxypropyl methylcellulose K100M, 5.25g of microcrystalline cellulose, and 5.25g of sodium bicarbonate are mixed evenly, and then dry granulated and tableted to obtain glycyrrhiza flavonoids physical mixture tablets.
[0106] Test Example 1 Thermal Analysis (DSC) Measurement
[0107] 3-5 mg of each of glycyrrhizin, hydroxypropyl-β-cyclodextrin, β-cyclodextrin, poloxamer, hypromellose and two physical mixtures thereof, and the glycyrrhizin multi-element supramolecular inclusion complex prepared in Examples 1 and 2 of the present invention (washed with ethyl acetate and dried) were pressed into tablets and subjected to thermal analysis (DSC) determination. The results are shown in Table 1. Figures 1 to 9 .
[0108] like Figures 1 to 9As shown: Licorice flavonoids have characteristic peaks at 491.42℃, 528.31℃, etc., poloxamer has characteristic peaks at 54.22℃, etc., and hydroxypropyl methylcellulose has characteristic peaks at 481.17℃, etc.; Licorice flavonoids-hydroxypropyl-β-cyclodextrin-poloxamer-hydroxypropyl methylcellulose multi-supramolecular inclusion complex has characteristic peaks at 539.38℃, etc., and its physical mixture has characteristic peaks at 52.9℃, 512.24℃, etc.; Licorice flavonoids-β-cyclodextrin-poloxamer-hydroxypropyl methylcellulose multi-supramolecular inclusion complex has characteristic peaks at 539.38℃, etc., and its physical mixture has characteristic peaks at 52.9℃, 512.24℃, etc. The dextrin-poloxamer-hydroxypropyl methylcellulose multi-element supramolecular inclusion complex has characteristic peaks at 444.23°C, 537.5°C, etc., while its physical mixture has characteristic peaks at 52.34°C, 393.58°C, 530.66°C, etc.; this indicates that the DSC spectrum of the glycyrrhizin multi-element supramolecular inclusion complex is different from that of its physical mixture, and the characteristic peaks of glycyrrhizin, poloxamer and hypromellose DSC in the multi-element supramolecular inclusion complex disappear, proving that a new phase has been formed.
[0109] Test Example 2 High Performance Liquid Chromatography Determination
[0110] 1. Take 0.4 g of the glycyrrhiza flavonoid multi-element supramolecular inclusion complex prepared in Example 1 of the present invention, add 20 mL of ethyl acetate to wash, shake for 2 min and filter, discard the filtrate, add 20 mL of ethyl acetate to the residue, shake for 2 min and filter, collect the second washing liquid of ethyl acetate, evaporate to dryness, add anhydrous ethanol to dissolve, make up to 25 mL, filter, inject, and the liquid chromatogram of the second washing liquid of ethyl acetate is as follows: Fig.10 As shown;
[0111] 2. At the same time, weigh 0.2 g of the multi-component supramolecular inclusion complex washed with ethyl acetate twice and dried, add 80% ethanol and ultrasonicate for 20 min, then dilute to 50 mL, filter, and inject. The liquid chromatogram of the multi-component supramolecular inclusion complex of glycyrrhiza flavonoids washed with ethyl acetate twice is as shown in Fig.11 As shown;
[0112] 3. Weigh 0.1g of licorice flavonoids, add anhydrous ethanol and ultrasonically dissolve, dilute to 50mL, filter, inject, and the liquid chromatogram of licorice flavonoids is as follows: Fig.12 shown.
[0113] The liquid chromatography conditions were: C18 column, detection wavelength of 300 nm, flow rate of 1.0 mL / min, acetonitrile and 0.1% phosphoric acid solution as mobile phase, gradient of acetonitrile 19%→45% from 0 to 60 min, acetonitrile 45%→62% from 60 to 80 min, acetonitrile 62%→90% from 80 to 92 min.
[0114] Depend on Figure 10 to Figure 12It can be seen that the glycyrrhiza flavonoids multi-element supramolecular inclusion complex prepared by the present invention is washed with ethyl acetate, and there is no chromatographic peak in the second ethyl acetate washing solution, and the retention time of each component peak of the liquid fingerprint spectrum of the glycyrrhiza flavonoids multi-element supramolecular inclusion complex after the second ethyl acetate washing is extracted with 80% ethanol is consistent with that of the glycyrrhiza flavonoids original drug, indicating that the glycyrrhiza flavonoids component contained in the multi-element supramolecular inclusion complex is consistent with the glycyrrhiza flavonoids original drug component, proving that the glycyrrhiza flavonoids component is included in the inclusion complex, and the multi-element supramolecular inclusion complex does not change the chemical composition of glycyrrhiza flavonoids.
[0115] Test Example 3 Determination of total flavonoids content by ultraviolet spectrophotometry
[0116] Take 50mg of sample, put it in a 25mL volumetric bottle, add 0.5mL of water, add 20mL of anhydrous ethanol after dissolution, ultrasonicate for 20min, add anhydrous ethanol to the scale, shake well, filter, dilute 10 times with anhydrous ethanol, and mix well. Take liquiritin as the control, measure the absorbance at a wavelength of 280nm, and calculate the total flavonoid content in licorice flavonoids. The blank excipient test was carried out in the same way, and it was found that the excipient did not interfere with the determination of total flavonoids.
[0117] Test Example 4 Encapsulation Efficiency Determination
[0118] Take 50 mg of each of the glycyrrhizin multi-component supramolecular inclusion complex, glycyrrhizin-cyclodextrin binary inclusion complex (Comparative Examples 1-2) and glycyrrhizin-cyclodextrin-poloxamer ternary inclusion complex (Comparative Examples 3-4) prepared in Examples 1-15 of the present invention, wash with ethyl acetate, collect the ethyl acetate solution, evaporate to dryness and dissolve in anhydrous ethanol, fix the volume to 25 mL, filter, dilute 10 times with anhydrous ethanol, take glycyrrhizin as a control, measure the absorbance at a wavelength of 280 nm, measure the total flavonoid content in the glycyrrhizin not included, measure the total flavonoid content of the inclusion complex with reference to the method of Test Example 3, calculate the encapsulation efficiency, and the results are shown in Table 3.
[0119] Encapsulation efficiency (%) = (1-unencapsulated drug amount / total drug amount of inclusion compound) × 100%
[0120] As shown in Table 3, the encapsulation efficiency of the glycyrrhizin multi-component supramolecular inclusion complex prepared by the present invention is significantly higher than that of the glycyrrhizin-cyclodextrin binary inclusion complex (Comparative Examples 1-2).
[0121] Test Example 5 Solubility Test
[0122] Weigh an appropriate amount of the glycyrrhizin multi-component supramolecular inclusion complex prepared in Examples 1 to 15 of the present invention, a glycyrrhizin-cyclodextrin binary inclusion complex (Comparative Examples 1 to 2), a glycyrrhizin-cyclodextrin-poloxamer ternary inclusion complex (Comparative Examples 3 to 4), a glycyrrhizin-poloxamer suspension (Comparative Example 5), and a glycyrrhizin original drug, add them to 10 mL of artificial gastric juice to prepare a supersaturated solution, stir in a water bath at 37 ° C for 24 h, filter, take 1 mL of the filtrate, dilute it with an appropriate amount of anhydrous ethanol, measure the absorbance at a wavelength of 280 nm with glycyrrhizin as a control, and calculate the solubility of total flavonoids in glycyrrhizin. The results are shown in Table 3.
[0123] Table 3 Encapsulation efficiency and solubility of licorice flavonoids
[0124]
[0125] As shown in Table 3, the water solubility of the glycyrrhizin multi-component supramolecular inclusion complex prepared by the present invention is significantly better than that of the glycyrrhizin original drug, the glycyrrhizin-cyclodextrin binary inclusion complex (Comparative Examples 1-2) and the glycyrrhizin-poloxamer suspension (Comparative Example 5).
[0126] Test Example 6 Dissolution Test
[0127] Take the glycyrrhizin multi-component supramolecular inclusion complex prepared in Examples 1 to 15 of the present invention, the glycyrrhizin-cyclodextrin binary inclusion complex (Comparative Examples 1 to 2), the glycyrrhizin-cyclodextrin-poloxamer ternary inclusion complex (Comparative Examples 3 to 4), the glycyrrhizin-poloxamer suspension (Comparative Example 5), and the glycyrrhizin original drug, and measure the drug dissolution at different times. The dissolution medium is artificial gastric juice, 100r / min, temperature (37°C ± 0.5), 5mL is sampled at regular intervals, filtered, diluted 10 times with anhydrous ethanol, and the absorbance is measured at a wavelength of 280nm with glycyrrhizin as a control, and the cumulative dissolution percentage is calculated. The results are shown in Table 4 and Fig.13 .
[0128] Table 4 Dissolution test of licorice flavonoids
[0129]
[0130]
[0131] The results show that the cumulative dissolution percentage of the glycyrrhizin flavonoids multi-component supramolecular inclusion complex prepared by the present invention is significantly higher than that of the glycyrrhizin flavonoids original drug, the glycyrrhizin flavonoids-poloxamer suspension (Comparative Example 5), and the glycyrrhizin flavonoids-cyclodextrin binary inclusion complex (Comparative Examples 1-2). Compared with Comparative Examples 1-5, the time for the glycyrrhizin flavonoids multi-component supramolecular inclusion complex prepared by the present invention to reach the maximum cumulative dissolution percentage is significantly prolonged, and the dissolution and release rate of glycyrrhizin flavonoids can be delayed.
[0132] Test Example 7 Release Test
[0133] The glycyrrhizin multi-component supramolecular inclusion compound gastric retention sustained-release preparations prepared in Examples 16 to 30 of the present invention, glycyrrhizin-cyclodextrin binary inclusion compound tablets (Comparative Examples 6 to 7), glycyrrhizin-cyclodextrin-poloxamer ternary inclusion compound tablets (Comparative Examples 8 to 9), glycyrrhizin-poloxamer suspension tablets (Comparative Example 10), glycyrrhizin physical mixture tablets (Comparative Example 11), and Examples 1 to 2 (after dry granulation and tableting) were taken respectively to measure the drug release at different times. The release medium was artificial gastric juice, 100 r / min, and the temperature was (37°C ± 0.5). A stopwatch was used to time the time from when the tablet was placed in the release medium to when the tablet floated to the liquid surface as the floating time, and the time from the start of floating to the end of the experiment as the continuous floating time. The results are shown in Table 5. 5 mL of samples were taken at regular intervals, filtered, diluted 10 times with anhydrous ethanol, and the absorbance was measured at a wavelength of 280 nm with liquiritin as a control to calculate the cumulative release percentage. The results are shown in Table 5 and Fig.14 .
[0134] Table 5 Release test of licorice flavonoids
[0135]
[0136]
[0137] The release test results show that the cumulative release percentage of the multi-component supramolecular inclusion compound gastric retention sustained-release preparation of glycyrrhizin prepared by the present invention is significantly higher than that of the glycyrrhizin physical mixture tablets (Comparative Example 11), glycyrrhizin-poloxamer suspension tablets (Comparative Example 10), and glycyrrhizin-cyclodextrin binary inclusion compound tablets (Comparative Examples 6-7). Compared with Comparative Examples 6-11, the time for the glycyrrhizin multi-component supramolecular inclusion compound gastric retention sustained-release preparation prepared by the present invention to reach the maximum cumulative release percentage is significantly prolonged, which can delay the dissolution rate of glycyrrhizin and prolong the gastric retention time of glycyrrhizin.
[0138] It can be seen from the floating time and continuous floating time that the licorice flavonoids multi-supramolecular inclusion compound gastric retention sustained-release preparation prepared by the present invention has a floating time of less than 10s and a continuous floating time of more than 12h, has good floating performance, and is significantly better than other preparations.
[0139] Test Example 8 Stability Test
[0140] The glycyrrhizin multi-supramolecular inclusion compound gastric retention sustained-release preparations prepared in Examples 16 to 30 of the present invention and Comparative Examples 6 to 11 were packaged in aluminum foil and placed under accelerated test conditions of a temperature of 37±1°C and a relative humidity of 75%. Samples were taken at 0, 1, 2, and 3 months, respectively. The total flavonoid content in glycyrrhizin was determined by the method of Test Example 3, and the cumulative release percentages at 2h and 8h were determined by the method of Test Example 7. The results are shown in Table 6.
[0141] Table 6 Stability test
[0142]
[0143] The results show that as the storage time of the accelerated test is prolonged, the total flavonoid content and cumulative release percentage of the glycyrrhizin flavonoid multi-component supramolecular inclusion gastric retention sustained-release preparation and glycyrrhizin flavonoid-cyclodextrin-poloxamer ternary inclusion tablets (Comparative Examples 8-9) prepared by the present invention do not change significantly, while the cumulative release percentage of the glycyrrhizin flavonoid binary inclusion tablets (Comparative Examples 6-7) and glycyrrhizin flavonoid poloxamer suspension tablets (Comparative Example 10) decreases significantly, which may be due to the instability of the system causing some glycyrrhizin flavonoids to separate and precipitate from the system. The cumulative release percentage of the glycyrrhizin flavonoid multi-component supramolecular inclusion gastric retention sustained-release preparation is significantly better than that of Comparative Examples 6-7, Comparative Example 10 and Comparative Example 11, indicating that the glycyrrhizin flavonoid multi-component supramolecular inclusion gastric retention sustained-release preparation prepared by the present invention has good stability and can effectively prevent the system from phase separation.
[0144] Test Example 9 Anti-peptic ulcer animal test
[0145] 1. Experimental animals: 30 male rabbits, weighing 2.3-2.7 kg, provided by the Animal Experiment Center of Shenyang Medical College.
[0146] 2. Establishment of animal model: Intraperitoneal injection of 10% chloral hydrate 3.5ml / kg anesthesia, fixed on the operating table, cut the abdominal hair below the xiphoid process to prepare the skin, open the abdomen about 10cm, separate the stomach and place it on sterile gauze soaked in saline and antibiotics. About 5mm below the lesser curvature of the stomach, place a glass tube with an inner diameter of 5mm vertically on the serosal surface of the anterior wall of the stomach, inject 0.1mL of acetic acid into the tube, and continuously stimulate and damage the serosal surface of the stomach for 60s. Use a cotton swab to absorb the acetic acid in the glass tube and then use a cotton swab dipped in saline to gently wipe twice, pull the greater omentum to cover the acetic acid injury site and return the stomach to the abdominal cavity, then suture it in layers (Note: water was given on the day of modeling, and free diet was given from the next day), and a gastric ulcer model was obtained.
[0147] 3. Grouping and dosing regimen: divided into ulcer control group, licorice flavonoids ordinary tablet group (prepared according to comparative example 11), licorice flavonoids multi-element supramolecular inclusion compound gastric retention sustained-release tablet group (prepared according to example 16, specification 50 mg / tablet), 10 in each group. On the third day after surgery, drug treatment was started, the dose was 100 mg / kg, once a day, and the ulcer control group was given an equal volume of normal saline. Treatment course: 30 days.
[0148] 4. Efficacy evaluation
[0149] (1) Ultrasound observation: Use ultrasound to observe the retention, movement and disintegration process of tablets in the stomach.
[0150] (2) Changes in ulcer area: Cut the stomach open along the greater curvature of the stomach, collect the gastric contents, and slowly rinse with 4°C saline. Use the ulcer area (S) as the efficacy evaluation index, and use a vernier caliper to measure the longest diameter of the ulcer and the widest diameter perpendicular to the longest diameter. S = π × longest diameter × widest diameter × 1 / 4.
[0151] 5. Statistical processing of experimental data: SPSS17.0 statistical software was used for data analysis. The measurement data were expressed as (x±s). One-way analysis of variance was used to compare the means of multiple samples. The t-test was used to compare the two groups. P<0.05 was considered a significant difference and statistically significant.
[0152] Test results: The results of rabbit B-ultrasound observation showed that the ordinary tablets of glycyrrhizin original medicine were retained in the rabbit stomach for about 2 hours, and the gastric retention sustained-release preparation of glycyrrhizin multi-component supramolecular inclusion complex was retained in the rabbit stomach for about 6 hours. The sustained-release preparation significantly prolonged the retention time of glycyrrhizin in the stomach.
[0153] The results of the gastric ulcer efficacy test are shown in Table 7. Compared with the ordinary tablets of glycyrrhizin original medicine, the glycyrrhizin multi-element supramolecular inclusion compound gastric retention sustained-release preparation prepared by the present invention has a significant anti-ulcer effect on rabbit gastric ulcer, and has a significant anti-ulcer and repair effect on the gastric ulcer surface.
[0154] Table 7 Effect of Licorice Flavonoids on the Treatment of Gastric Ulcers in Rabbits
[0155] Group Number of animals <![CDATA[Ulcer area (mm 2 )]]> P Control group 10 131.5±12.6 — Ordinary film group 10 47.29±4.71 <0.05* Sustained-release tablet group of the present invention 10 16.68±3.14 <0.05**
[0156] *: compared with the control group; **: compared with the common tablets group.
[0157] Test Example 10 Pharmacokinetic Test
[0158] 1. Administration and blood sample collection: Rabbits, 2.5-3.0 kg, male, provided by the Animal Experiment Center of Shenyang Medical College. Divided into two groups, gavage was respectively administered with Licorice Flavonoid Multi-element Supramolecular Inclusion Gastric Retention Sustained Release Tablets (prepared according to Example 16, specification 50 mg / tablet) or Licorice Flavonoid Ordinary Tablets (prepared according to Comparative Example 11), 6 tablets per rabbit, Licorice Chalcone A is one of the main active ingredients of Licorice Flavonoids. The blood sampling time was 1, 2, 3, 4, 5, 6, 7, 8 hours, blood was collected from the ear vein and placed in a heparinized centrifuge tube, frozen for later use.
[0159] 2. Blood sample processing method: Take 1 mL of blood sample, add 1 mL of methanol, ultrasonicate in ice water for 2 min, centrifuge for 5 min, take the supernatant for HPLC analysis, and determine the mass concentration of Licoricechalcone A.
[0160] 3. Liquid chromatography conditions: chromatographic column: C18 column; mobile phase: methanol: water (9:1, v:v); flow rate: 1 mL / min; detection wavelength: 372 nm.
[0161] 4. Standard curve: Weigh 3.6 mg of licorice chalcone A standard, prepare 50 mL of mobile phase solution, and then dilute it with the mobile phase in equal multiples to obtain a series of concentrations of licorice chalcone A solution, and store it in the refrigerator. Take a rabbit, collect blood from the ear vein and place it in a heparinized 2 mL centrifuge tube, 1 mL of blood in each tube, a total of twelve tubes. Add 0.1 mL of licorice chalcone A standard solution to each tube and shake it. After drying under reduced pressure at room temperature, add 1 mL of methanol to each tube, ultrasonicate in ice water for 2 minutes, centrifuge for 5 minutes, and take the supernatant for HPLC analysis. Use the concentration of licorice chalcone A in the blood sample as the horizontal coordinate and its peak area as the vertical coordinate to perform linear regression, and the linear regression equation is Y=460.35X+69.553, R 2 =0.9975, and the linear relationship was good in the concentration range of 0.05 to 7.20 μg / mL.
[0162] 5. Blood drug concentration and time curve: Determine the mass concentration of licorice chalcone A in blood samples at different blood collection times, and draw the blood drug concentration-time curve of licorice chalcone A, see Fig.15 The blood drug concentration data were processed using DrugAnd Statistics 1.0 Chinese version pharmacokinetic software to calculate the AUC of glycyrrhizin flavonoid multi-component supramolecular inclusion complex gastric retention sustained-release tablets and glycyrrhizin flavonoid ordinary tablets, as shown in Table 8.
[0163] RF (relative bioavailability) = (AUC1 / AUC2) × 100%
[0164] Table 8 Main pharmacokinetic parameters of licoricechalcone A after administration to rabbits in each group
[0165] Group AUC (μg·h / mL) <![CDATA[t max (h)]]> <![CDATA[C max (μg / mL)]]> Ordinary film group 5.36±0.47 1.0±0.0 2.56±0.17 Sustained-release tablet group of the present invention 14.80±0.62 5.0±0.0 2.82±0.21
[0166] The test results show that the peak time of the common tablets of Licorice Flavonoids is 1 hour, and the peak time of the Licorice Flavonoids multi-element supramolecular inclusion compound gastric retention sustained-release tablets is 5 hours. Compared with the common tablets of Licorice Flavonoids original medicine, the relative bioavailability (RF) of the Licorice Flavonoids multi-element supramolecular inclusion compound gastric retention sustained-release tablets is 276.1%. The Licorice Flavonoids multi-element supramolecular inclusion compound gastric retention sustained-release preparation prepared by the present invention significantly improves the bioavailability of Licorice Chalcone A.
[0167] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.
Claims
1. Licorice flavonoids multi-component supramolecular inclusion complex, It is characterized in that The invention is prepared from the following raw materials in parts by weight: 10 parts of glycyrrhizin, 10 to 30 parts of poloxamer, 10 to 100 parts of cyclodextrin and 1 to 10 parts of hydroxypropyl methylcellulose.
2. The method for preparing the glycyrrhiza flavonoids multi-component supramolecular inclusion compound according to claim 1, It is characterized in that The following steps are involved: (1) mixing glycyrrhizin and poloxamer with ethanol to obtain a mixed solution 1, then adding water to the mixed solution 1 and continuing to mix, and then adding cyclodextrin and stirring to obtain a mixed solution 2; (2) adding water to hydroxypropyl methylcellulose and stirring to obtain a mixed solution 3, mixing the mixed solution 3 with the mixed solution 2 described in step (1), and drying to obtain a glycyrrhizin multi-component supramolecular inclusion complex.
3. The method for preparing the glycyrrhiza flavonoid multi-component supramolecular inclusion compound according to claim 2, It is characterized in that The licorice flavonoids are licorice flavonoids extracts extracted from the residue after water extraction of licorice, and the content of flavonoid compounds in the licorice flavonoids is ≥80.0%; The poloxamer is poloxamer 188; The cyclodextrin is β-cyclodextrin or hydroxypropyl-β-cyclodextrin; The hypromellose is hypromellose K100M.
4. The method for preparing the glycyrrhiza flavonoids multi-component supramolecular inclusion compound according to claim 3, It is characterized in that The mass ratio of the glycyrrhiza flavonoids to ethanol in step (1) is 10:40-120, the volume fraction of the ethanol is 90-95%, and the mixing temperature with the ethanol is 40-60°C.
5. The method for preparing the glycyrrhiza flavonoid multi-element supramolecular inclusion compound according to claim 4, It is characterized in that The mass ratio of the glycyrrhiza flavonoids to water in step (1) is 10:100-400; The stirring temperature is 40-60° C. and the stirring time is 0.5-2 h.
6. The method for preparing the glycyrrhiza flavonoid multi-component supramolecular inclusion compound according to claim 5, It is characterized in that The mass ratio of the hypromellose to water in step (2) is 1:40-50; The stirring temperature is 30-40° C. and the stirring time is 3-5 hours.
7. The method for preparing the glycyrrhiza flavonoid multi-component supramolecular inclusion compound according to claim 6, It is characterized in that In step (2), the temperature of the mixed solution 3 and the mixed solution 2 when mixed is 30-40°C.
8. The method for preparing the glycyrrhiza flavonoids multi-component supramolecular inclusion compound according to claim 7, It is characterized in that The drying in step (2) is spray drying, with an air inlet temperature of 160-180°C and an air outlet temperature of 70-80°C.
9. A gastric retention sustained-release preparation of glycyrrhiza flavonoids multi-component supramolecular inclusion compound, It is characterized in that The invention is composed of the glycyrrhiza flavonoid multi-element supramolecular inclusion compound according to claim 1, microcrystalline cellulose and sodium bicarbonate in a mass ratio of 100:5-15:5-10.
10. Use of the glycyrrhizin flavonoids multi-component supramolecular inclusion compound according to claim 1 or the glycyrrhizin flavonoids multi-component supramolecular inclusion compound gastric retention sustained-release preparation according to claim 9 in the preparation of drugs for treating gastric ulcer or anti-tumor.
Citation Information
Patent Citations
Production method of water-soluble licoflavone
CN102140144A
Gastric antiulcer sustained-release dropping pill for treating gastric and duodenal bulbar ulcers and preparation method thereof
CN106822226A
Cited By
Preparation method for licoflavone multi-component supramolecular inclusion complex and gastric retention sustained-release formulation thereof and use thereof
WO2026040785A1
